Pre-HCT mosaicism increases relapse risk and lowers survival in acute lymphoblastic leukemia patients post-unrelated HCT.
Wang Y, Zhou W, Wang J, Karaesmen E, Tang H, McCarthy PL, Pasquini MC, Wang Y, McReynolds LJ, Katki HA, Machiela MJ, Yeager M, Pooler L, Sheng X, Haiman CA, Van Den Berg D, Spellman SR, Wang T, Kuxhausen M, Chanock SJ, Lee SJ, Clay-Gilmour AI, Hahn TE, Gadalla SM, Sucheston-Campbell LE.
Wang Y, et al. Among authors: wang j, wang t.
Blood Adv. 2021 Jan 12;5(1):66-70. doi: 10.1182/bloodadvances.2020003366.
Blood Adv. 2021.
PMID: 33570634
Free PMC article.